Terms: = Brain cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED
419 results:
1. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes.
Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY
J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348
[TBL] [Abstract] [Full Text] [Related]
2. Clinical role of NDRG2-based methylation status on survival pattern of glioblastoma.
Swellam M; Khalifa MK; Nageeb AM; Ezz El-Arab L; El-Mahdy M; El-Bahy K; Sayed Mahmoud M
Int J Immunopathol Pharmacol; 2024; 38():3946320241250294. PubMed ID: 38686946
[TBL] [Abstract] [Full Text] [Related]
3. AF1q is a universal marker of neuroblastoma that sustains n-myc expression and drives tumorigenesis.
Oskouian B; Lee JY; Asgharzadeh S; Khan R; Zhang M; Weisbrod JR; Choi YJ; Puri L; Aguilar AE; Zhao P; Saba JD
Oncogene; 2024 Apr; 43(16):1203-1213. PubMed ID: 38413795
[TBL] [Abstract] [Full Text] [Related]
4. Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas.
Pohl LC; Leitheiser M; Obrecht D; Schweizer L; Wefers AK; Eckhardt A; Raffeld M; Sturm D; Pajtler KW; Rutkowski S; Fukuoka K; Ichimura K; Bockmayr M; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):24. PubMed ID: 38265522
[TBL] [Abstract] [Full Text] [Related]
5. Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas.
Aboubakr O; Métais A; Maillard J; Hasty L; Brigot E; Berthaud C; Lacombe J; Pucelle N; Raynal J; Appay R; Varlet P; Tauziède-Espariat A
Histopathology; 2024 Apr; 84(5):893-899. PubMed ID: 38253970
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play.
Satgunaseelan L; Sy J; Shivalingam B; Sim HW; Alexander KL; Buckland ME
Pathology; 2024 Mar; 56(2):158-169. PubMed ID: 38233331
[TBL] [Abstract] [Full Text] [Related]
7. Partial Response to Naxitamab for brain Metastasis in Neuroblastoma.
Onyeukwu C; Williams A; Seyboth B; Muñoz L; Scaria G; Kent P
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e188-e190. PubMed ID: 38189408
[TBL] [Abstract] [Full Text] [Related]
8. Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.
Appin CL; Hong C; Suwala AK; Hilz S; Mathur R; Solomon DA; Smirnov IV; Stevers NO; Shai A; Wang A; Berger MS; Chang SM; Phillips JJ; Costello JF
Neuro Oncol; 2024 Apr; 26(4):640-652. PubMed ID: 38141254
[TBL] [Abstract] [Full Text] [Related]
9. Targeted Degradation of XIAP is Sufficient and Specific to Induce Apoptosis in mycn-overexpressing High-risk Neuroblastoma.
Choo Z; Koh X; Wong MRE; Ashokan RM; Ali Ahamed NSB; Kang C; Kuick CH; Chang KTE; Larisch S; Loh AHP; Chen ZX
Cancer Res Commun; 2023 Nov; 3(11):2386-2399. PubMed ID: 37874199
[TBL] [Abstract] [Full Text] [Related]
10. Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.
Fares J; Petrosyan E; Kanojia D; Dmello C; Cordero A; Duffy JT; Yeeravalli R; Sahani MH; Zhang P; Rashidi A; Arrieta VA; Ulasov I; Ahmed AU; Miska J; Balyasnikova IV; James CD; Sonabend AM; Heimberger AB; Lesniak MS
J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 37847564
[TBL] [Abstract] [Full Text] [Related]
11. Comparative Analysis of the Embryonal brain Tumors Based on Their Molecular Features.
Shcherbina V; Kovalevska L; Pedachenko E; Malysheva T; Kashuba E
Discov Med; 2023 Oct; 35(178):733-749. PubMed ID: 37811612
[TBL] [Abstract] [Full Text] [Related]
12. Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.
Chen W; Guo S; Wang Y; Shi Y; Guo X; Liu D; Li Y; Wang Y; Xing H; Xia Y; Li J; Wu J; Liang T; Wang H; Liu Q; Jin S; Qu T; Li H; Yang T; Zhang K; Wang Y; Ma W
Cancer Med; 2023 Sep; 12(18):18666-18678. PubMed ID: 37667984
[TBL] [Abstract] [Full Text] [Related]
13. The evolution of spinal cord surgery: history, people, instruments, and results.
Shimony N; Fehnel K; Abbott IR; Jallo GI
Childs Nerv Syst; 2023 Oct; 39(10):2687-2700. PubMed ID: 37658937
[TBL] [Abstract] [Full Text] [Related]
14. Genetics in ophthalmology: molecular blueprints of retinoblastoma.
Marković L; Bukovac A; Varošanec AM; Šlaus N; Pećina-Šlaus N
Hum Genomics; 2023 Sep; 17(1):82. PubMed ID: 37658463
[TBL] [Abstract] [Full Text] [Related]
15. Serum brain-derived neurotrophic factor (BDNF) as predictors of childhood neuroblastoma relapse.
Xiong X; Zeng M; Peng X; Feng C; Li C; Weng W; Li Y
BMC Cancer; 2023 Jul; 23(1):670. PubMed ID: 37460933
[TBL] [Abstract] [Full Text] [Related]
16. Pediatric Precision Medicine at the National cancer Center Japan: Prospective Genomic Study of Pediatric Patients with cancer as Part of the TOP-GEAR Project.
Tao K; Yamazaki F; Kubo T; Sunami K; Kumamoto T; Arakawa A; Sugiyama M; Watanabe Y; Nakajima M; Shirakawa N; Tanimura K; Koyama T; Hirata M; Sudo K; Tanabe N; Watanabe T; Yoshida T; Kitami M; Yoshida A; Yatabe Y; Nakano Y; Ohira M; Kamijo T; Nakazawa A; Kato M; Ichimura K; Kohno T; Yamamoto N; Hishiki T; Ichikawa H; Ogawa C
JCO Precis Oncol; 2023 Jul; 7():e2200266. PubMed ID: 37410973
[TBL] [Abstract] [Full Text] [Related]
17. Utility of Comprehensive Genomic Profiling for Precise Diagnosis of Pediatric-Type Diffuse High-Grade Glioma.
Makino K; Otani Y; Fujii K; Ishida J; Hirano S; Suruga Y; Washio K; Nishida K; Yanai H; Tomida S; Ennishi D; Date I
Acta Med Okayama; 2023 Jun; 77(3):323-330. PubMed ID: 37357634
[TBL] [Abstract] [Full Text] [Related]
18. Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
Massimino M; Vennarini S; Buttarelli FR; Antonelli M; Colombo F; Minasi S; Pecori E; Ferroli P; Giussani C; Schiariti M; Schiavello E; Biassoni V; Erbetta A; Chiapparini L; Nigro O; Boschetti L; Gianno F; Miele E; Modena P; De Cecco L; Pollo B; Barretta F
J Neurooncol; 2023 Jul; 163(3):577-586. PubMed ID: 37326761
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors.
Mohanty SK; Diwaker P; Mishra SK; Jha S; Lobo A; Panda SP; Sharma S; Kumar M; Arora S; Mallik V; Jain D; Jain E; Chakrabarti I; Varshney J; Beg A; Dixit M; Baisakh MR; Naik S; Sahoo SK; Akgul M; Balzer BL; Amin MB; Parwani AV
Int J Surg Pathol; 2024 Apr; 32(2):294-303. PubMed ID: 37312579
[TBL] [Abstract] [Full Text] [Related]
20. Genomic profiles of IDH-mutant gliomas: mycn-amplified IDH-mutant astrocytoma had the worst prognosis.
Lee K; Kim SI; Kim EE; Shim YM; Won JK; Park CK; Choi SH; Yun H; Lee H; Park SH
Sci Rep; 2023 Apr; 13(1):6761. PubMed ID: 37185778
[TBL] [Abstract] [Full Text] [Related]
[Next]
